Unknown

Dataset Information

0

Detection of chromosomal breakpoints in patients with developmental delay and speech disorders.


ABSTRACT: Delineating candidate genes at the chromosomal breakpoint regions in the apparently balanced chromosome rearrangements (ABCR) has been shown to be more effective with the emergence of next-generation sequencing (NGS) technologies. We employed a large-insert (7-11 kb) paired-end tag sequencing technology (DNA-PET) to systematically analyze genome of four patients harbouring cytogenetically defined ABCR with neurodevelopmental symptoms, including developmental delay (DD) and speech disorders. We characterized structural variants (SVs) specific to each individual, including those matching the chromosomal breakpoints. Refinement of these regions by Sanger sequencing resulted in the identification of five disrupted genes in three individuals: guanine nucleotide binding protein, q polypeptide (GNAQ), RNA-binding protein, fox-1 homolog (RBFOX3), unc-5 homolog D (C.elegans) (UNC5D), transmembrane protein 47 (TMEM47), and X-linked inhibitor of apoptosis (XIAP). Among them, XIAP is the causative gene for the immunodeficiency phenotype seen in the patient. The remaining genes displayed specific expression in the fetal brain and have known biologically relevant functions in brain development, suggesting putative candidate genes for neurodevelopmental phenotypes. This study demonstrates the application of NGS technologies in mapping individual gene disruptions in ABCR as a resource for deciphering candidate genes in human neurodevelopmental disorders (NDDs).

SUBMITTER: Utami KH 

PROVIDER: S-EPMC3946304 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature

altmetric image

Publications


Delineating candidate genes at the chromosomal breakpoint regions in the apparently balanced chromosome rearrangements (ABCR) has been shown to be more effective with the emergence of next-generation sequencing (NGS) technologies. We employed a large-insert (7-11 kb) paired-end tag sequencing technology (DNA-PET) to systematically analyze genome of four patients harbouring cytogenetically defined ABCR with neurodevelopmental symptoms, including developmental delay (DD) and speech disorders. We c  ...[more]

Similar Datasets

| S-EPMC7481981 | biostudies-literature
| S-EPMC6594421 | biostudies-literature
| S-EPMC6633906 | biostudies-literature
| S-EPMC6375720 | biostudies-literature
| S-EPMC7756316 | biostudies-literature
| S-EPMC5500957 | biostudies-literature
| S-EPMC5968608 | biostudies-literature
| S-EPMC3573196 | biostudies-literature
| S-EPMC7887192 | biostudies-literature
| S-EPMC4104679 | biostudies-literature